Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss

Morgan L. Prust, Kourosh Jafari-Khouzani, Jayashree Kalpathy-Cramer, Pavlina Polaskova, Tracy T. Batchelor, Elizabeth R. Gerstner, Jorg Dietrich

Research output: Contribution to journalLetter

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)289-291
Number of pages3
JournalNeuro-Oncology
Volume20
Issue number2
DOIs
StatePublished - Jan 22 2018
Externally publishedYes

Fingerprint

Glioblastoma
Neuroimaging
Vascular Endothelial Growth Factor A
Therapeutics
Gray Matter
White Matter

Keywords

  • brain atrophy
  • chemoradiation
  • glioblastoma
  • neuroimaging
  • neurotoxicity

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Prust, M. L., Jafari-Khouzani, K., Kalpathy-Cramer, J., Polaskova, P., Batchelor, T. T., Gerstner, E. R., & Dietrich, J. (2018). Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss. Neuro-Oncology, 20(2), 289-291. https://doi.org/10.1093/neuonc/nox217

Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss. / Prust, Morgan L.; Jafari-Khouzani, Kourosh; Kalpathy-Cramer, Jayashree; Polaskova, Pavlina; Batchelor, Tracy T.; Gerstner, Elizabeth R.; Dietrich, Jorg.

In: Neuro-Oncology, Vol. 20, No. 2, 22.01.2018, p. 289-291.

Research output: Contribution to journalLetter

Prust, ML, Jafari-Khouzani, K, Kalpathy-Cramer, J, Polaskova, P, Batchelor, TT, Gerstner, ER & Dietrich, J 2018, 'Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss', Neuro-Oncology, vol. 20, no. 2, pp. 289-291. https://doi.org/10.1093/neuonc/nox217
Prust, Morgan L. ; Jafari-Khouzani, Kourosh ; Kalpathy-Cramer, Jayashree ; Polaskova, Pavlina ; Batchelor, Tracy T. ; Gerstner, Elizabeth R. ; Dietrich, Jorg. / Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss. In: Neuro-Oncology. 2018 ; Vol. 20, No. 2. pp. 289-291.
@article{63efe1125efc415f932b1ae3026c92c2,
title = "Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss",
keywords = "brain atrophy, chemoradiation, glioblastoma, neuroimaging, neurotoxicity",
author = "Prust, {Morgan L.} and Kourosh Jafari-Khouzani and Jayashree Kalpathy-Cramer and Pavlina Polaskova and Batchelor, {Tracy T.} and Gerstner, {Elizabeth R.} and Jorg Dietrich",
year = "2018",
month = "1",
day = "22",
doi = "10.1093/neuonc/nox217",
language = "English (US)",
volume = "20",
pages = "289--291",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss

AU - Prust, Morgan L.

AU - Jafari-Khouzani, Kourosh

AU - Kalpathy-Cramer, Jayashree

AU - Polaskova, Pavlina

AU - Batchelor, Tracy T.

AU - Gerstner, Elizabeth R.

AU - Dietrich, Jorg

PY - 2018/1/22

Y1 - 2018/1/22

KW - brain atrophy

KW - chemoradiation

KW - glioblastoma

KW - neuroimaging

KW - neurotoxicity

UR - http://www.scopus.com/inward/record.url?scp=85041188499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041188499&partnerID=8YFLogxK

U2 - 10.1093/neuonc/nox217

DO - 10.1093/neuonc/nox217

M3 - Letter

C2 - 29315410

AN - SCOPUS:85041188499

VL - 20

SP - 289

EP - 291

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 2

ER -